Amneal Pharmaceuticals (AMRX) EV to CFO (2018 - 2026)

Amneal Pharmaceuticals has reported EV to CFO for 9 years, with the latest figure at 258.16 in Q2 2026.

• On a quarterly basis, EV to CFO fell 953.54% year-over-year to 258.16 in Q2 2026; TTM through Jun 2026 was 27.32, a 278.27% increase from a year earlier, with the FY2025 full-year figure at 11.06, up 35.44% from the prior year.
• EV to CFO was 258.16 for Q2 2026 at Amneal Pharmaceuticals, down from 144.1 in the prior quarter.
• The five-year high for EV to CFO was 356.36 in Q1 2025, with the low at 424.25 in Q1 2024.
• Average EV to CFO over 5 years is 20.09, with a median of 11.1 recorded in 2022.
• The sharpest annual moves came in 2024 and 2025: EV to CFO sank 19379.69% in 2024, then soared 184.0% in 2025.
• Over 5 years, EV to CFO stood at 25.9 in 2022, then jumped by 151.46% to 13.33 in 2023, then surged by 53.12% to 20.4 in 2024, then jumped by 41.39% to 28.85 in 2025, then plunged by 994.83% to 258.16 in 2026.
• The last three EV to CFO figures came in at 258.16 (Q2 2026), 144.1 (Q1 2026), and 28.85 (Q4 2025), per Business Quant data.